Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Endocrinology

Understanding Triple A (Allgrove) Syndrome

At a Glance

Triple A (Allgrove) syndrome is a rare inherited condition caused by AAAS gene changes. It classically combines absent tears, achalasia, and adrenal insufficiency that does not respond normally to the body’s ACTH signal, while neurological or autonomic problems may develop over time.

Triple A syndrome, also known as Allgrove syndrome, is an extremely rare genetic condition that affects multiple systems in the body. It is estimated to occur in approximately 1 in 1,000,000 people worldwide based on small published cohorts [1][2]. Because it is so rare and its symptoms can appear at different times, many researchers believe it may be underdiagnosed [3].

The condition is named for a “triad” of three classic features, though it is now widely recognized that a fourth category of symptoms—neurological and autonomic dysfunction—is often a core part of the syndrome [4][5].

The Classic Triad and the “Fourth A”

Triple A syndrome is defined by three primary medical challenges, though not every person will have all three at the time of diagnosis, and some may never develop all of them [6]:

  1. Alacrima: A reduced or total absence of tear production. This is often the very first sign of the syndrome [7].
  2. Achalasia: A disorder of the esophagus (the tube connecting the mouth to the stomach) that makes it difficult for food and liquid to pass into the stomach. This occurs because the muscles of the lower esophagus fail to relax properly [8].
  3. Adrenal Insufficiency: Specifically, a type that is resistant to the hormone ACTH (adrenocorticotropic hormone). The adrenal glands fail to produce enough cortisol, a “stress hormone” vital for maintaining energy, blood sugar, and blood pressure [8][6].

In addition to these three, many patients—up to 79% in some specific study cohorts—may eventually develop autonomic or neurological dysfunction [9]. This can affect “automatic” body processes like sweating, heart rate, and blood pressure, or lead to challenges with coordination, speech, and muscle strength [4][10]. When these symptoms are present, doctors sometimes refer to the condition as 4A syndrome [5].

The Genetic Cause

Triple A syndrome is an autosomal recessive disorder [8]. This means a child must inherit two copies of a non-working gene—one from each parent—to develop the condition. Parents are typically “carriers” who have one non-working copy and one working copy, and they usually show no symptoms themselves [11].

The condition is caused by mutations in the AAAS gene, which provides instructions for making a protein called ALADIN [8].

  • The Nuclear Pore: ALADIN is part of the nuclear pore complex, a gatekeeper that controls what moves in and out of the cell’s nucleus (where DNA is stored) [12].
  • Protein Transport: When the ALADIN protein is faulty or missing, certain other proteins cannot enter the nucleus correctly. Researchers propose this can lead to increased oxidative stress—a type of cellular damage—and may interfere with the cell’s ability to repair its DNA [12][13].
  • Variable Impact: While we know the gene involved, researchers are still working to understand exactly why this protein defect affects the tear glands, the esophagus, the adrenal glands, and the nervous system so specifically [14].

Common Patterns of Progression

Symptoms rarely appear all at once. Instead, they often emerge in a staggered timeline that spans from infancy into adulthood, though finding one feature should prompt a medical evaluation for the others [7][15].

  • Infancy: Alacrima is usually the earliest sign and is often present from birth or early infancy [7]. Parents may notice their baby cries without producing visible tears.
  • Early Childhood: Adrenal insufficiency often appears in early childhood, sometimes presenting as low blood sugar (hypoglycemia) or extreme fatigue during illness [15][16]. However, it can occasionally wait until adulthood to manifest [17].
  • Childhood to Adolescence: Achalasia typically begins to cause symptoms, such as difficulty swallowing or vomiting after meals, during the school-age years or adolescence, though it can appear earlier or later [18][19].
  • Variable Onset: Neurological symptoms are often the most variable. They may appear in childhood but frequently become more noticeable or can be progressive as a person enters adulthood [9][10].

Wide Variation in Severity

It is important to understand that Triple A syndrome affects every person differently. Even siblings with the same genetic mutation can have very different symptoms and levels of severity [20]. Some individuals may have a complete triad by age 6, while others may only have one or two features for many years [10][6].

Because the neurological and autonomic features can be progressive, regular follow-up with a coordinated care team is essential to monitor for new developments over time [9].

Common questions in this guide

What are the three classic features of Triple A syndrome?
The classic triad is alacrima, meaning little or no tear production; achalasia, which makes it difficult for food to pass through the esophagus; and adrenal insufficiency that does not respond normally to ACTH. A person may not have all three features when the condition is first recognized.
What does the fourth A mean in Triple A syndrome?
The fourth A refers to autonomic or neurological problems, such as abnormal sweating, changes in heart rate or blood pressure, poor coordination, speech difficulty, or reduced muscle strength. These problems vary widely and may become more noticeable or progress with age.
How is Triple A syndrome inherited?
Triple A syndrome follows an autosomal recessive inheritance pattern. A child usually develops the condition after inheriting two non-working copies of the AAAS gene, one from each parent, while parents with one non-working copy are usually symptom-free carriers.
When do symptoms of Triple A syndrome usually appear?
Absent tears often begin at birth or during infancy. Adrenal insufficiency may appear in early childhood, achalasia often causes symptoms during the school-age years or adolescence, and neurological or autonomic symptoms can begin at varying ages, including adulthood.
How can a clinician check for reduced tear production?
A Schirmer test can formally measure tear production, even when dry eyes are not obvious. A clinician may consider this result together with symptoms and other evaluations when assessing possible Triple A syndrome.
Can siblings with Triple A syndrome have different symptoms?
Yes. Even siblings with the same AAAS mutation can have different combinations, severity, and timing of symptoms; some develop the full triad early, while others have only one or two features for years.

Get notified when new evidence is published on Triple A syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Alacrima as a Harbinger of Adrenal Insufficiency in a Child with Allgrove (AAA) Syndrome.

    Brown B, Agdere L, Muntean C, David K

    The American journal of case reports 2016; (17()):703-706 doi:10.12659/ajcr.899546.

    PMID: 27698338
  2. 2

    Recurrent pulmonary infection leads to the diagnosis of triple A syndrome: a case report.

    Ali S, Murad MS, Hamdan H, Nakawa W

    Journal of medical case reports 2022; (16(1)):304 doi:10.1186/s13256-022-03509-1.

    PMID: 35902876
  3. 3

    Clinical heterogeneity and molecular profile of triple A syndrome: a study of seven cases.

    Singh K, Puri RD, Bhai P, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2018; (31(7)):799-807 doi:10.1515/jpem-2018-0023.

    PMID: 29874194
  4. 4

    Very early and severe presentation of Triple A syndrome - case report and review of the literature.

    Cehic M, Mitrovic K, Vukovic R, et al.

    Frontiers in endocrinology 2024; (15()):1431383 doi:10.3389/fendo.2024.1431383.

    PMID: 39387047
  5. 5

    A triple A syndrome with neurological findings; c464G>A mutation in the AAAS gene.

    Boz PB, Koç AF, Bereketoğlu MB

    Ideggyogyaszati szemle 2025; (78(5-6)):207-210 doi:10.18071/isz.78.0207.

    PMID: 40476452
  6. 6

    A broad range of symptoms in allgrove syndrome: single center experience in Southeast Anatolia.

    Polat R, Ustyol A, Tuncez E, Guran T

    Journal of endocrinological investigation 2020; (43(2)):185-196 doi:10.1007/s40618-019-01099-2.

    PMID: 31435881
  7. 7

    The Clinical and Biological Characterization of Triple A Syndrome (Allgrove Syndrome) in 12 Pediatric Patients.

    Bouarab I, Yakine F, Alaoui-Inboui FZ, et al.

    Cureus 2026; (18(5)):e109586 doi:10.7759/cureus.109586.

    PMID: 42359238
  8. 8

    Triple-A Syndrome (TAS): An In-Depth Overview on Genetic and Phenotype Heterogeneity.

    Pogliaghi G, Cangiano B, Duminuco P, et al.

    Protein and peptide letters 2020; (27(12)):1192-1203 doi:10.2174/0929866527666200613215449.

    PMID: 32533814
  9. 9

    Phenotype-genotype spectrum of AAA syndrome from Western India and systematic review of literature.

    Patt H, Koehler K, Lodha S, et al.

    Endocrine connections 2017; (6(8)):901-913 doi:10.1530/EC-17-0255.

    PMID: 29180348
  10. 10

    Clinical and Genetic Heterogeneity of Triple A Syndrome: A Multicenter Study.

    Celebi D, Kiraz A, Khojakulov Z, et al.

    Hormone research in paediatrics 2026; 1 doi:10.1159/hrp/adaag030.

    PMID: 42886620
  11. 11

    Case Report: First case of Triple A syndrome diagnosed in French Guiana: clinical presentation, molecular confirmation, and literature review.

    Diop M, Roosler Billy T, Elenga N

    Frontiers in pediatrics 2026; (14()):1906922 doi:10.3389/fped.2026.1906922.

    PMID: 42846567
  12. 12

    Role of ALADIN in human adrenocortical cells for oxidative stress response and steroidogenesis.

    Jühlen R, Idkowiak J, Taylor AE, et al.

    PloS one 2015; (10(4)):e0124582 doi:10.1371/journal.pone.0124582.

    PMID: 25867024
  13. 13

    The nucleoporin ALADIN regulates Aurora A localization to ensure robust mitotic spindle formation.

    Carvalhal S, Ribeiro SA, Arocena M, et al.

    Molecular biology of the cell 2015; (26(19)):3424-38 doi:10.1091/mbc.E15-02-0113.

    PMID: 26246606
  14. 14

    Compensation for chronic oxidative stress in ALADIN null mice.

    Jühlen R, Peitzsch M, Gärtner S, et al.

    Biology open 2018; (7(1)) doi:10.1242/bio.030742.

    PMID: 29362278
  15. 15

    Allgrove syndrome in Colombia: clinical characterization and evidence of a possible founder effect.

    Botero Hernandez JA, Varela Macias ED, Lopera Cañaveral MV, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; doi:10.1515/jpem-2026-0358.

    PMID: 42764719
  16. 16

    "Crying without tears" as an early diagnostic sign-post of triple A (Allgrove) syndrome: two case reports.

    Tibussek D, Ghosh S, Huebner A, et al.

    BMC pediatrics 2018; (18(1)):6 doi:10.1186/s12887-017-0973-y.

    PMID: 29334914
  17. 17

    Allgrove (Triple A) Syndrome: A Case Report from the Kashmir Valley.

    Misgar RA, Pala NA, Ramzan M, et al.

    Endocrinology and metabolism (Seoul, Korea) 2015; (30(4)):604-6 doi:10.3803/EnM.2015.30.4.604.

    PMID: 26354489
  18. 18

    Peroral endoscopic myotomy provides effective and sustained relief for achalasia in Allgrove syndrome: a long-term comparative cohort study.

    Liu Y, Hu Y, Guo T, et al.

    Frontiers in medicine 2026; (13()):1819125 doi:10.3389/fmed.2026.1819125.

    PMID: 42078430
  19. 19

    Allgrove syndrome with amyotrophy.

    Soares MC, Lins OG, Lima de Carvalho JR, et al.

    Practical neurology 2022; (22(3)):213-215 doi:10.1136/practneurol-2021-003192.

    PMID: 34969826
  20. 20

    Insights into genetic and clinical profiles of triple A syndrome in Sudanese children.

    Musa SA, Abdullah MA, Hassan SS, et al.

    Frontiers in endocrinology 2025; (16()):1617552 doi:10.3389/fendo.2025.1617552.

    PMID: 40917361

This page is for informational purposes only and does not constitute medical advice about Triple A syndrome. A qualified clinician and genetics team should interpret symptoms, testing, and monitoring for your child or family.